EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Miltefosine and Nifuratel Combination: A Promising Therapy for the Treatment of Leishmania donovani Visceral Leishmaniasis

Estela Melcon-Fernandez iD, Giulio Galli iD, Carlos García-Estrada iD, Rafael Balaña-Fouce iD, Rosa M Reguera iD, Yolanda Pérez-Pertejo

International Journal of Molecular Sciences · 13.01.2023 · 24 (2) · 1635

DOI: 10.3390/ijms24021635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 13.01.2023. Verfasst von Estela Melcon-Fernandez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department Ciencias Biomédicas, Universidad de León, Campus de Vegazana s/n P.C, 24071 León, Spain. Hauptthemen laut MEDLINE: Leishmaniasis, Visceral, Leishmania donovani, Nifuratel, Antiprotozoal Agents. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Economy, Industry and Competitiveness, R.M.R. EMF, EU PRIMA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Visceral leishmaniasis is a neglected vector-borne tropical disease caused by Leishmania donovani and Leishmania infantum that is endemic not only in East African countries, but also in Asia, regions of South America and the Mediterranean Basin. For the pharmacological control of this disease, there is a limited number of old and, in general, poorly adherent drugs, with a multitude of adverse effects and low oral bioavailability, which favor the emergence of resistant pathogens. Pentavalent antimonials are the first-line drugs, but due to their misuse, resistant Leishmania strains have emerged worldwide. Although these drugs have saved many lives, it is recommended to reduce their use as much as possible and replace them with novel and more friendly drugs. From a commercial collection of anti-infective drugs, we have recently identified nifuratel—a nitrofurantoin used against vaginal infections—as a promising repurposing drug against a mouse model of visceral leishmaniasis. In the present work, we have tested combinations of miltefosine—the only oral drug currently used against leishmaniasis—with nifuratel in different proportions, both in axenic amastigotes from bone marrow and in intracellular amastigotes from infected Balb/c mouse spleen macrophages, finding a potent synergy in both cases. In vivo evaluation of oral miltefosine/nifuratel combinations using a bioimaging platform has revealed the potential of these combinations for the treatment of this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leishmaniasis, VisceralLeishmania donovaniNifuratelAntiprotozoal AgentsAnimalsFemaleMicePhosphorylcholine

Stichwörter der Autor:innen

Leishmaniadrug combinationsdrug repurposingmiltefosinenifuratel

Substanzen

NifuratelAntiprotozoal AgentsmiltefosinePhosphorylcholine

Autor:innen und Institutionen

  • Department Ciencias Biomédicas, Universidad de León, Campus de Vegazana s/n P.C, 24071 León, Spain.

ORCID-Profile: Estela Melcon-Fernandez, Giulio Galli, Carlos García-Estrada, Rafael Balaña-Fouce, Rosa M Reguera

Förderung

  • Ministry of Economy, Industry and Competitiveness
  • R.M.R. EMF
  • EU PRIMA
  • FPI scholarship
  • MINECO
  • FPI scholarship supported by AEI

Zitieren

APA

Melcon-Fernandez, E., Galli, G., García-Estrada, C., Balaña-Fouce, R., Reguera, R. M., & Pérez-Pertejo, Y. (2023). Miltefosine and Nifuratel Combination: A Promising Therapy for the Treatment of Leishmania donovani Visceral Leishmaniasis. International Journal of Molecular Sciences, 24(2), 1635. https://doi.org/10.3390/ijms24021635

Vancouver

Melcon-Fernandez E, Galli G, García-Estrada C, Balaña-Fouce R, Reguera RM, Pérez-Pertejo Y. Miltefosine and Nifuratel Combination: A Promising Therapy for the Treatment of Leishmania donovani Visceral Leishmaniasis. International Journal of Molecular Sciences. 2023;24(2):1635. doi:10.3390/ijms24021635

BibTeX
@article{MelconFernandez2023,
  author = {Melcon-Fernandez, Estela and Galli, Giulio and García-Estrada, Carlos and Balaña-Fouce, Rafael and Reguera, Rosa M and Pérez-Pertejo, Yolanda},
  title = {Miltefosine and Nifuratel Combination: A Promising Therapy for the Treatment of Leishmania donovani Visceral Leishmaniasis},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {2},
  pages = {1635},
  doi = {10.3390/ijms24021635}
}
Kostenlos starten →